Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
URGN compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
URGN
UroGen Pharma Ltd.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
URGN
UroGen Pharma Ltd.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes
Method
›
Moved together
URGN
with
LLY
Uncorrelated: r 0.16 · 499D.
No shared co-movers.
URGN, solid
LLY, hatched
r = correlation
Bar = r to r 0.75
Source: daily closes
URGN
UroGen Pharma Ltd.
Change
24.77
▼
−3.72%
· post 24.38
Mkt cap
$1.3B
Revenue
$89M
Q3 FY26
Revenue
$110M
FY25
LLY
ELI Lilly & Co
Change
1,360.90
▼
−0.28%
· post 1,358.90
Closed
Nov 6 '26
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Closed
Nov 6 '26
URGN
UroGen Pharma Ltd.
vs
LLY
ELI Lilly & Co
24.77
▼
−3.72%
post 24.38
Price
1,360.90
▼
−0.28%
post 1,358.90
$1.3B
Mkt cap
$1.2T
Q3 FY26
$89M
Revenue
$24.4B
Q3 FY26
FY25
$110M
Revenue
$65.2B
FY25
Change
Change
URGN
24.77
▼
−3.72%
vs
LLY
1,360.90
▼
−0.28%
Closed
Nov 6 '26